Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality
- PMID: 20486197
- PMCID: PMC6647593
- DOI: 10.1002/jcla.20383
Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality
Abstract
Background: Crimean-Congo hemorrhagic fever (CCHF) is an acute illness affecting multiple organ systems and characterized by ecchymosis, visceral bleeding, and hepatic dysfunction. In this study, we aimed to investigate the profile of coagulopathy markers (platelet count, activated partial tromboplastin time (aPTT), prothrombin time (PT), international normalized ratio (INR), fibrinogen, protein C, protein S, antithrombin III, activated protein C resistance (APCR), and D-dimer) and their clinical significance in 83 CCHF-infected patients.
Subjects and methods: We studied 83 CCHF patients who were admitted to Ankara Numune Education and Research Hospital during the spring and summer of2007. We compared the coagulopathy markers of fatal CCHF patients (n=9) with nonfatal cases (n=74).
Results: Platelet count, PT, aPTT, INR, and fibrinogen were prognostic factors associated with mortality for CCHF. Especially, platelet count<20 x 10(9) cells/l and aPTT>60 sec were important. Protein C, protein S, APCR, and antithrombin III levels were not associated with mortality.
Conclusion: Laboratory tests including classical parameters (platelet count, PT, aPTT, INR, and fibrinogen) of coagulopathy seem to be enough for the followup of CCHF. Protein S, protein C, APCR, and D-dimer levels were not associated with mortality.
(c) 2010 Wiley-Liss, Inc.
Similar articles
-
Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.Int J Infect Dis. 2012 Feb;16(2):e89-93. doi: 10.1016/j.ijid.2011.06.005. Epub 2011 Dec 6. Int J Infect Dis. 2012. PMID: 22154082
-
Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients.Arch Virol. 2018 Mar;163(3):609-616. doi: 10.1007/s00705-017-3653-1. Epub 2017 Nov 20. Arch Virol. 2018. PMID: 29159591
-
Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):441-4. doi: 10.1177/1076029612440035. Epub 2012 Mar 19. Clin Appl Thromb Hemost. 2013. PMID: 22431857
-
The association between mortality due to COVID-19 and coagulative parameters: a systematic review and meta-analysis study.BMC Infect Dis. 2024 Dec 2;24(1):1373. doi: 10.1186/s12879-024-10229-y. BMC Infect Dis. 2024. PMID: 39623325 Free PMC article.
-
Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever.Antiviral Res. 2016 Aug;132:233-43. doi: 10.1016/j.antiviral.2016.06.011. Epub 2016 Jul 1. Antiviral Res. 2016. PMID: 27378224 Review.
Cited by
-
Thrombocytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infections.PLoS One. 2013;8(1):e53236. doi: 10.1371/journal.pone.0053236. Epub 2013 Jan 2. PLoS One. 2013. PMID: 23301047 Free PMC article.
-
Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus.Viruses. 2016 Apr 21;8(4):106. doi: 10.3390/v8040106. Viruses. 2016. PMID: 27110812 Free PMC article. Review.
-
Prognostic Value of Ratios of Inflammatory Markers in the Prognosis of Crimean-Congo Hemorrhagic Fever.Trop Med Infect Dis. 2025 Apr 8;10(4):99. doi: 10.3390/tropicalmed10040099. Trop Med Infect Dis. 2025. PMID: 40278772 Free PMC article.
-
Can serum ferritin level predict disease severity in patients with crimean-congo hemorrhagic Fever?Eurasian J Med. 2013 Jun;45(2):108-14. doi: 10.5152/eajm.2013.22. Eurasian J Med. 2013. PMID: 25610262 Free PMC article.
-
A Syrian golden hamster model recapitulating ebola hemorrhagic fever.J Infect Dis. 2013 Jan 15;207(2):306-18. doi: 10.1093/infdis/jis626. Epub 2012 Oct 8. J Infect Dis. 2013. PMID: 23045629 Free PMC article.
References
-
- Whitehouse CA. Crimean‐Congo hemorrhagic fever. Antiviral Res 2004;64:145–160. - PubMed
-
- Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean‐Congo hemorrhagic fever. Rev Infect Dis 1989;11:794–800. - PubMed
-
- Vorou R, Pierroutsakos IN, Maltezou HC. Crimean‐Congo hemorrhagic fever. Curr Oppin Infect Dis 2007;20:495–500. - PubMed
-
- Centers for Disease Control and Prevention (CDC) . Update: management of patients with suspected viral hemorrhagic fever‐United States. MMWR Morb Mortal Wkly Rep 1995;44:475–479. - PubMed
-
- Cevik MA, Erbay A, Bodur H, et al. Clinical and laboratory features of Crimean‐Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008;12:374–379. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources